Update shared on04 Aug 2025
Fair value Decreased 18%The consensus analyst price target for Avantor has been significantly reduced, primarily due to notable declines in both revenue growth forecasts and net profit margin expectations, resulting in a new fair value estimate of $14.12.
What's in the News
- Emmanuel Ligner appointed President and CEO, succeeding Michael Stubblefield; Ligner brings extensive life sciences leadership experience from GE Life Sciences, Cytiva, and Cerba HealthCare.
- Avantor added to Russell 2500 Index.
- Avantor added to Russell 2500 Value Index.
- Avantor added to Russell 2500 Value Benchmark.
Valuation Changes
Summary of Valuation Changes for Avantor
- The Consensus Analyst Price Target has significantly fallen from $17.15 to $14.12.
- The Consensus Revenue Growth forecasts for Avantor has significantly fallen from 3.2% per annum to 2.5% per annum.
- The Net Profit Margin for Avantor has significantly fallen from 7.61% to 6.43%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.